(Q46031139)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19404582%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Dose-finding and pharmacokinetic study of orally administered indibulin (D-24851) to patients with advanced solid tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19404582%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

R L Oostendorp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19404582%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

P O Witteveen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19404582%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

L D Vainchtein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19404582%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

M Schot

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19404582%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

A Nol

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19404582%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

H Rosing

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19404582%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

E E Voest

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19404582%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

J H M Schellens

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19404582%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

30 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19404582%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19404582%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19404582%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19404582%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

163-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19404582%20AND%20SRC:MED&resulttype=core&format=json

Motor neuropathy due to docetaxel and paclitaxel

27 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10637-009-9244-6

Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere).

21 January 2018

1 reference

12 December 2020

Mechanism of action of antitumor drugs that interact with microtubules and tubulin

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors.

1 reference

12 December 2020

Role of taxanes in lung-cancer chemotherapy

1 reference

12 December 2020

Neurotoxicity of antineoplastic agents

1 reference

12 December 2020

Chemotherapeutic neuropathy

1 reference

12 December 2020

D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity

1 reference

12 December 2020

THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS

1 reference

12 December 2020

A pharmacokinetic and safety study of a novel polymeric paclitaxel formulation for oral application

1 reference

12 December 2020

Novel paclitaxel formulations for oral application: a phase I pharmacokinetic study in patients with solid tumours

1 reference

12 December 2020

Quantitative analysis of D-24851, a novel anticancer agent, in human plasma and urine by liquid chromatography coupled with tandem mass spectrometry

1 reference

12 December 2020

A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer

1 reference

12 December 2020